Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 113.50
-8.35 (-6.85%)
At close: Mar 27, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 5.88 billion as of March 27, 2026. Its market cap has decreased by -28.09% in one year.
Market Cap
5.88B
Enterprise Value
7.08B
Revenue
6.20B
Ranking
n/a
PE Ratio
35.68
Stock Price
113.50
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 5.88B, an increase of 928.60%. That is a compound annual growth rate of 10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 5.88B | -18.71% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermenta Biotech | 10.57B |
| Wanbury | 8.47B |
| Fredun Pharmaceuticals | 8.28B |
| Anuh Pharma | 7.16B |
| Bharat Parenterals | 6.84B |
| Sudarshan Pharma Industries | 5.74B |
| Kilitch Drugs (India) | 5.33B |
| Jenburkt Pharmaceuticals | 4.45B |